Close
Back to mobile site

Form 3 METLIFE INC For: May 01 Filed by: DEBEL MARLENE

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


May 7, 2019 5:52 PM EDT
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
DEBEL MARLENE
(Last) (First) (Middle)
METLIFE, INC.
200 PARK AVENUE
(Street)
NEW YORK NY 10166
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2019 		3. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Risk Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 30,085
D
 
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units   (1)   (1) Common Stock 7,565 (1) D  
Employee Stock Options (right to buy)   (2) 02/25/2023 Common Stock 5,513 31.15 D  
Employee Stock Options (right to buy)   (2) 02/24/2024 Common Stock 10,911 45.15 D  
Employee Stock Options (right to buy)   (2) 02/23/2025 Common Stock 9,703 45.91 D  
Employee Stock Options (right to buy)   (2) 02/22/2026 Common Stock 13,107 34.33 D  
Employee Stock Options (right to buy)   (2) 02/27/2027 Common Stock 10,600 46.85 D  
Employee Stock Options (right to buy)   (2) 03/01/2028 Common Stock 10,712 45.5 D  
Employee Stock Options (right to buy)   (2) 02/25/2029 Common Stock 12,013 44.65 D  
Explanation of Responses:
1. Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. 1,179 shares were granted on February 28, 2017, 2,382 shares were granted on March 2, 2018, 4,004 shares were granted on February 26, 2019.
2. The reported number of underlying shares represent outstanding unexercised options that became (or will become) exercisable in three installments on each of the first three anniversaries of the Grant Date. The expiration date is the day before the tenth anniversary of the Grant Date.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Mark A. Schuman, authorized signer 05/07/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
EXHIBIT 24

LIMITED POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS

TO WHOM IT MAY CONCERN:

Pursuant to the authorization set forth in the instructions for the filing of
Form 3, Form 4, and Form 5, respectively (hereinafter referred to as the
"Reports"), under the requirements of the Securities Exchange Act of 1934, as
amended, the undersigned hereby designates and authorizes each of STEPHEN W.
GAUSTER, JEANNETTE N. PINA and MARK A. SCHUMAN to execute and file, or cause to
be filed, such Reports, and any amendments thereto, on behalf of the
undersigned, with the Securities and Exchange Commission and any other proper
bodies at any time when the filing of said Reports is in order, containing such
information as STEPHEN W. GAUSTER, JEANNETTE N. PINA, and MARK A. SCHUMAN may
deem advisable.

The authority of STEPHEN W. GAUSTER, JEANNETTE N. PINA, and MARK A. SCHUMAN
under this authorization shall continue until the undersigned is no longer
required to file Reports with regard to the undersigned's ownership of or
transactions in securities of MetLife, Inc., unless earlier revoked by the
undersigned in writing.

The undersigned acknowledges that STEPHEN W. GAUSTER, JEANNETTE N. PINA , and
MARK A. SCHUMAN are not assuming any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934, as amended.

Signature: /s/ Marlene Debel

Name: MARLENE DEBEL

Date: 3/8/19

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings